Patents full text · MLC-0201
CPC subclass A61K
Preparations for medical, dental or toiletry purposes
| No. | Publication | Title | Published | Assignee |
|---|---|---|---|---|
| 1 | US2026104418A1 | Claudin18 antibodies and methods of treating cancer | 2026-04-16 | |
| 2 | US2026103696A1 | Compositions and methods for adoptive cell therapy for cancer | 2026-04-16 | |
| 3 | US2026103539A1 | Multispecific antigen binding proteins for tumor-targeting of NK cells and use thereof | 2026-04-16 | |
| 4 | US2026103529A1 | Amino Acid Sequences Directed Against the Melanocortin 4 Receptor and Polypeptides Comprising the Same for the Treatment of MC4R-Related Diseases and Disorders | 2026-04-16 | |
| 5 | US2026103524A1 | Nkg2d-nkp46 cell adapter molecule and use thereof | 2026-04-16 | |
| 6 | US2026103514A1 | Antibodies that specifically bind cldn6 or cd3 and bispecific antibodies that specifically bind cldn6 and cd3 | 2026-04-16 | |
| 7 | US2026103507A1 | Nucleic acid construct and use thereof | 2026-04-16 | |
| 8 | US2026103502A1 | Chimeric Antigen Receptor and Natural Killer Cells Expressing Same | 2026-04-16 | |
| 9 | US2026103494A1 | Gene therapy treatment | 2026-04-16 | |
| 10 | US2026103485A1 | Compound based on oxidative stress and anti-amyloid aggregation mechanism, preparation method therefor and use thereof | 2026-04-16 | |
| 11 | US2026103479A1 | Prodrugs of opicapone | 2026-04-16 | |
| 12 | US2026103444A1 | 8-hydroxyquinoline compound and use thereof | 2026-04-16 | |
| 13 | US2026102527A1 | CD8B-binding polypeptides | 2026-04-16 | |
| 14 | US2026102516A1 | Capsid variants and methods of using the same | 2026-04-16 | |
| 15 | US2026102507A1 | Camptothecin derivative for treating or preventing cancer and antibody-drug conjugate thereof | 2026-04-16 | |
| 16 | US2026102503A1 | Nanocomposites for enhanced cellular payload delivery | 2026-04-16 | |
| 17 | US2026102499A1 | Compositions with reduced nitrosamine impurities | 2026-04-16 | |
| 18 | US2026102497A1 | Photosensitive hybrid vesicles and the fabrication methods and applications thereof | 2026-04-16 | |
| 19 | US2026102485A1 | Neutralizing anti-tl1a monoclonal antibodies | 2026-04-16 | |
| 20 | US2026102484A1 | Adjuvants for enhancing the immune response | 2026-04-16 | |
| 21 | US2026102454A1 | Dual acting polymers in an osmotic film for topical application to treat inflammatory diseases and cytokine release syndrome | 2026-04-16 | |
| 22 | US2026102446A1 | Use of oncolytic viruses, alone or in combination with a checkpoint inhibitor, for the treatment of cancer | 2026-04-16 | |
| 23 | US2026102442A1 | Novel lactic acid bacteria and use thereof | 2026-04-16 | |
| 24 | US2026102435A1 | Engineered cells and implantable elements for treatment of disease | 2026-04-16 | |
| 25 | US2026102391A1 | Inhibition of a tripartite vor protein complex in multicellular organisms | 2026-04-16 | |
| 26 | US2026102371A1 | Process for synthesizing a formulation of galangin-loaded hydrogel for expedited wound healing | 2026-04-16 | |
| 27 | US2026102360A1 | Nano2 dodecafluoropentane emulsion as a cardiac arrest therapeutic | 2026-04-16 | |
| 28 | US2026102347A1 | Sulfur-Containing Ionizable Lipids for the Delivery of Therapeutic Agents | 2026-04-16 | |
| 29 | US12109311B2 | Lyophilization systems and methods | 2024-10-08 | MASSACHUSETTS INST TECHNOLOGY |
| 30 | US11771693B2 | Device for deterring abuse of drugs | 2023-10-03 | EIGHTY EIGHT PHARMA INC |
| 31 | US2022396796A1 | Rna for cancer therapy | 2022-12-15 | CUREVAC AG |
| 32 | US11358956B2 | Compounds containing polysubstituted benzo[d][1,3]oxathiole, benzo[d][1,3]oxathiole 3-oxide or benzo[d][1,3]oxathiole 3,3-dioxide and methods/uses thereof as agonists of G protein-coupled receptor 119 | 2022-06-14 | PRAMANA PHARMACEUTICALS INC |
| 33 | US11345113B2 | Composite protective sheet material | 2022-05-31 | CERIUM GROUP LTD |
| 34 | US2022076800A1 | Subject Modelling | 2022-03-10 | NEUROTECH RES PTY LTD |
| 35 | US11204423B2 | Micro robot and micro robot behavior measurement system | 2021-12-21 | DAEGU GYEONGBUK INST SCIENCE & TECH |
| 36 | US11191837B2 | Recombinant VWF formulations | 2021-12-07 | TAKEDA PHARMACEUTICALS CO |
| 37 | US11123312B2 | Engaging the cervical spinal cord circuitry to re-enable volitional control of hand function in tetraplegic subjects | 2021-09-21 | UNIV CALIFORNIA |
| 38 | US2021236576A1 | Composition for preventing or treating cancer comprising extracts of anemone raddeana, lonicera species, and aralia elata containing high concentration of antitumor saponins, and method for preparing same | 2021-08-05 | BACK JU YOUN |
| 39 | US2021171552A1 | Phosphoantigen prodrug compounds | 2021-06-10 | UNIV COLLEGE CARDIFF CONSULTANTS LTD |
| 40 | US10994045B2 | Process for making dry and stable hemostatic compositions | 2021-05-04 | BAXTER INT |
| 41 | US10952965B2 | Compositions and methods for drug delivery | 2021-03-23 | RABINOW BARRETT |
| 42 | US2020222319A1 | Manufacturing of pharmaceutical compositions | 2020-07-16 | FERRING INT CENTER SA |
| 43 | US10588908B2 | Methods of treating pediatric cancers | 2020-03-17 | LOXO ONCOLOGY INC |
| 44 | US10525059B2 | Pharmaceutical compositions comprising Afatinib | 2020-01-07 | FRESENIUS KABI ONCOLOGY LTD |
| 45 | US10513517B2 | Naphthyridine derivatives as alpha V beta 6 integrin antagonists for the treatment of E.G. fibrotic diseases | 2019-12-24 | GLAXOSMITHKLINE IP DEV LTD |
| 46 | US10456975B2 | Multi-compartment capsule | 2019-10-29 | MULTIPLY LABS INC |
| 47 | US10406259B2 | Placental tissue grafts and improved methods of preparing and using the same | 2019-09-10 | MIMEDX GROUP INC |
| 48 | US2019175763A1 | Methods and systems for noninvasive control of brain cells and related vectors and compositions | 2019-06-13 | CALIFORNIA INST OF TECHN |
| 49 | US10266698B2 | Colorant compounds derived from genipin or genipin containing materials | 2019-04-23 | ECOFLORA S A S |
| 50 | US10265351B2 | Probiotic for infantile colic | 2019-04-23 | AB BIOTICS SA |
| 51 | US10231907B2 | Compositions for improving the health and appearance of skin | 2019-03-19 | ALGENIST HOLDINGS INC |
| 52 | US10137109B2 | Carbazole compounds and therapeutic uses of the compounds | 2018-11-27 | INCURON LLC |
| 53 | US2018296616A1 | Method for preparation of pharmacologically-relevant compounds from botanical sources | 2018-10-18 | RIVAS JOSE |
| 54 | US2018273597A1 | Compositions and methods relating to the treatment of diseases | 2018-09-27 | ALFACYTE LTD |
| 55 | US10039820B2 | West nile virus vaccine comprising WN-80E recombinant subunit protein | 2018-08-07 | HAWAII BIOTECH INC |
| 56 | US9901526B2 | Consumer goods product comprising functionalised lignin oligomer | 2018-02-27 | PROCTER & GAMBLE |
| 57 | US9827209B2 | Display system | 2017-11-28 | MICROSOFT TECHNOLOGY LICENSING LLC |
| 58 | US9730911B2 | Cannabis extracts and methods of preparing and using same | 2017-08-15 | UNITED CANNABIS CORP |
| 59 | US9700866B2 | Surfactant systems for delivery of organic compounds | 2017-07-11 | CHAUBAL MAHESH |
| 60 | US9700542B2 | Compounds as opioid receptor modulators | 2017-07-11 | JANSSEN PHARMACEUTICA NV |
| 61 | US9668966B2 | Cosmetic compositions comprising microalgal components | 2017-06-06 | TERRAVIA HOLDINGS INC |
| 62 | US9650680B2 | MicroRNAs and uses thereof | 2017-05-16 | ROSETTA GENOMICS LTD |
| 63 | US9592161B2 | Method of making pressure-sensitive adhesive article including active agent | 2017-03-14 | 3M INNOVATIVE PROPERTIES CO |
| 64 | US9585838B2 | Production of multivesicular liposomes | 2017-03-07 | HARTOUNIAN HARTOUN |
| 65 | US9580713B2 | Fluoride-responsive riboswitches, fluoride transporters, and methods of use | 2017-02-28 | UNIV YALE |
| 66 | US9541004B2 | Antagonist antibodies against EphB3 | 2017-01-10 | NOVARTIS AG |
| 67 | US9453082B2 | Polysaccharides from prasinococcales | 2016-09-27 | GLYCOMAR LTD |
| 68 | US9446226B2 | Drug-delivering composite structures | 2016-09-20 | ZILBERMAN MEITAL |
| 69 | US9441016B2 | Complete genome sequence of the methanogen Methanobrevibacter ruminantium | 2016-09-13 | ALTERMANN ERIC HEINZ |
| 70 | US9439932B2 | Pluripotent cells | 2016-09-13 | CELAVIE BIOSCIENCES LLC |
| 71 | US9421238B2 | Treatment of klebsiella pneumoniae with liposomally formulated glutathione | 2016-08-23 | UNIV EMORY |
| 72 | US9351953B2 | Cannabis conversion process | 2016-05-31 | STODOLA KELLY J |
| 73 | US9345498B2 | Methods of controlling magnetic nanoparticles to improve vascular flow | 2016-05-24 | PULSE THERAPEUTICS INC |
| 74 | US2016008467A1 | Method for the production of sub-micrometric particles and their theranostic use in oncology with a specific apparatus | 2016-01-14 | MBN NANOMATERIALIA SPA |
| 75 | US2015366933A1 | Treatment of klebsiella pneumoniae with liposomally formulated glutathione | 2015-12-24 | UNIV EMORY |
| 76 | US9108916B2 | Carbazole compounds and therapeutic uses of the compounds | 2015-08-18 | INCURON LLC |
| 77 | US9018160B2 | Peptide tyrosine tyrosine analogues | 2015-04-28 | BLOOM STEPHEN ROBERT |
| 78 | US2015089751A1 | Systems for custom coloration | 2015-04-02 | COLORIGHT LTD |
| 79 | US2015064278A1 | Continuous Methods for Treating Liquids and Manufacturing Certain Constituents (e.g., Nanoparticles) in Liquids, Apparatuses and Nanoparticles and Nanoparticle/Liquid Solution(s) Resulting Therefrom | 2015-03-05 | PIERCE DAVID KYLE |
| 80 | US8961969B2 | Antagonist antibodies against EphB3 | 2015-02-24 | NOVARTIS AG |
| 81 | US8951242B2 | Bacterium-based microrobot including magnetic particles | 2015-02-10 | UNIV NAT CHONNAM IND FOUND |
| 82 | US8765738B2 | Carbazole compounds and therapeutic uses of the compounds | 2014-07-01 | TUCKER JOHN |
| 83 | US8383769B2 | Peptides for inhibiting chemokine binding to chemokine receptors | 2013-02-26 | BIOKINE THERAPEUTICS LTD |
| 84 | US2013012555A1 | Compounds, Compositions and Methods for the Treatment of Islet Amyloid Polypeptide (IAPP) Accumulation in Diabetes | 2013-01-10 | LAKE THOMAS |
| 85 | US2012297556A1 | Soluble solid hair coloring article | 2012-11-29 | FELTS TIMOTHY JAMES |
| 86 | US2012245141A1 | Activators of human pyruvate kinase | 2012-09-27 | THOMAS CRAIG J |
| 87 | US8039440B2 | Peptides for inhibiting chemokine binding to chemokine receptors | 2011-10-18 | BIOKINE THERAPEUTICS LTD |
| 88 | US8007842B2 | Composition for inhalation therapy and methods of use | 2011-08-30 | TOWER LAB LTD |
| 89 | US2011171213A1 | Methods for treating pancreatic cancer | 2011-07-14 | HOUHOU LEILA |
| 90 | US2011117086A1 | Monoclonal antibodies to progastrin and their uses | 2011-05-19 | BIOREALITES S A S |
| 91 | US2011002857A1 | Oleaginous pharmaceutical and cosmetic foam | 2011-01-06 | FOAMIX LTD |
| 92 | US7851479B2 | Use of pyrimidinedione derivative for preventing or treating hepatitis C | 2010-12-14 | SAMJIN PHARM CO LTD |
| 93 | US2010030199A1 | Configurations And Methods For Power Generation In LNG Regasification Terminals | 2010-02-04 | FLUOR TECH CORP |
| 94 | US2010008938A1 | Self assembling amphiphilic polymers as antiviral agents | 2010-01-14 | DIWAN ANIL |
| 95 | US2009017090A1 | Devices and methods for delivering active agents to the osteomeatal complex | 2009-01-15 | ARENSDORF PATRICK A |
| 96 | US7429572B2 | Modified fluorinated nucleoside analogues | 2008-09-30 | PHARMASSET INC |
| 97 | US2008083414A1 | Detecting time periods associated with surgical phases and/or interventions | 2008-04-10 | GEN ELECTRIC |
| 98 | US7108125B2 | Extendable belt conveyor | 2006-09-19 | SIEMENS ENERGY & AUTOMAT |
| 99 | US2006186061A1 | Apparatus for the continuous separation of biological fluids into components and method of using same | 2006-08-24 | BRIGGS DENNIS |
| 100 | US2006094652A1 | Hybrid polypeptides with selectable properties | 2006-05-04 | LEVY ODILE E |
212 records in this listing. Patents full text (MLC-0201). Request the full dataset.